Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2013

Conditions
Age-related Macular DegenerationCentral Retinal Vein OcclusionDiabetic Macular Edema
Interventions
PROCEDURE

Xylocaine 2% Injectable Anesthetic

xylocaine 2% injection 0.1 cc

DRUG

Proparacaine Hydrochloride 0.5% Drop

Topical drop given first to the treated eye.

DRUG

Tetravisc 0.5% Gel

Gel applied to eye 3 times prior to treatment

DRUG

Acuvail

Anti-inflammatory drop given after treatment

DRUG

Intra-vitreal Anti-VEGF Drug

Intravitreal injection treating wet AMD or Diabetic Macular Edema or Retinal Vein Occlusion

Trial Locations (1)

33756

Retina Vitreous Associates of Florida, Clearwater

All Listed Sponsors
lead

Retina Vitreous Associates of Florida

OTHER

NCT01640171 - Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival | Biotech Hunter | Biotech Hunter